A. Alexis, K. Anders, A. Seetasith, and M. Holden, “Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria”, J of Skin, vol. 8, no. 1, p. s333, Jan. 2024.